CRISPR Therapeutics AG
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Zug
CRSP chart
What traders are saying about $CRSP
Latest postsCRISPR Therapeutics AG news
- CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 9.1% - What's Next?
MarketBeat ·
- CRISPR Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
Yahoo Finance ·
- A healthcare conference chat featuring CRISPR Therapeutics will stream live Nov. 17.
Stock Titan ·
- 3 Gene Editing Stocks Retail Investors Are Watching After BioAdvance
Yahoo Finance ·
- Mid-cap biotech catalysts: FDA dates, earnings, and pipeline data to watch
Yahoo Finance ·
- CRISPR Therapeutics Presents Phase 1b Data for CTX310® Demonstrating Reductions in ANGPTL3 and Triglycerides in Patients with Severe Hypertriglyceridemia at the American Heart Association (AHA) Scientific Sessions 2026
Yahoo Finance ·
- The CRISPR Therapeutics AG (NASDAQ:CRSP) Analysts Have Been Trimming Their Sales Forecasts
Simply Wall St ·
- CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- CRISPR Therapeutics AG (CRSP) interactive stock chart – Yahoo Finance
Yahoo Finance Singapore ·
- CRISPR Therapeutics Provides Update on Zugocabtagene Geleucel (Zugo-cel) in Refractory Rheumatologic Autoimmune Diseases
Yahoo Finance ·
- All 9 patients with inflammatory muscle disease met response measures in CRISPR Therapeutics' trial
Stock Titan ·
- CRSP Stock Price and Chart — NASDAQ:CRSP
TradingView ·
CRISPR Therapeutics AG key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.5M | $37.3M | $371.2M | $1.2M |
| Net income | -$581.6M | -$366.3M | -$153.6M | -$650.2M |
| Diluted EPS | $-6.47 | $-4.34 | $-1.94 | $-8.36 |
| Total assets (year end) | $2.27B | $2.24B | $2.23B | $2.24B |
| Cash and equivalents (year end) | $347.6M | $298.3M | $389.5M | $211.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About CRISPR Therapeutics AG
- Ticker
- CRSP (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Zug
- Incorporated in
- Switzerland
- Fiscal year end
- December 31
- SEC CIK
- 1674416
- Former names
- CRISPR Therapeutics AG
Frequently asked questions
What exchange is CRISPR Therapeutics AG listed on?
CRISPR Therapeutics AG trades on the Nasdaq under the ticker symbol CRSP.
What industry is CRISPR Therapeutics AG in?
CRISPR Therapeutics AG is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is CRISPR Therapeutics AG headquartered?
CRISPR Therapeutics AG's business address on file with the SEC is in Zug.
When does CRISPR Therapeutics AG's fiscal year end?
CRISPR Therapeutics AG's fiscal year ends on December 31.
How much revenue did CRISPR Therapeutics AG report?
CRISPR Therapeutics AG reported $3.5M in revenue for calendar year 2025, according to its SEC filings.